Skip to content
Search

Latest Stories

Pharmacy majors reassure on steady supply of medicines

Leading pharmacy chains said they are taking steps to maintain safe and steady supply of medicines and healthcare services as COVID-19 crisis looms large over the UK.

As people are stocking up on painkillers and hand sanitisers pharmacies have seen a surge in customers, forcing many to ration supplies.


“You might have noticed that we’ve set a limit on the number of certain items you can buy. Thank you for supporting us and appreciating these limits as we try to help as many people as possible,” Seb James, Managing Director Boots UK said in a statement on Tuesday (17 March).

James said the chain continues to have stock in the supply chain of hand sanitisers and other high demand products like children’s medicine, pain relief and hygiene products. Hand sanitisers are being sent to stores each day to meet the “exceptional demand,” he added.

Boots will also offer free delivery of prescriptions for their NHS online repeat prescription service.

In a separate statement, James appealed to the public to desist from panic buying.

“We ask our customers to speak to our teams for ways they can proactively manage their prescriptions if they are in self isolation; and to only buy the medicines they need now so we can make sure as many people as possible can access the products they need,” he said.

Toby Anderson, chief executive of LloydsPharmacy parent McKesson UK, said the company has processes in place with suppliers and manufacturers to help minimise the impact of shortages and ensure a consistent supply of critical products.

“Our priority is to make sure that everyone has access to the medication that they need, when they need it, so we are doing everything we can to ensure availability, despite increasing demand and supply challenges,” he said in a statement on Tuesday.

Anderson informed that the company, which also has AAH Pharmaceuticals in its fold, will not be building additional stockholding within its supply chain, in line with the Department of Health and Social Care guidelines, to limit the risk of future potential medicine shortages.

“We will continue to monitor unusual downstream sales patterns, and we will act where needed to mitigate the risk of inappropriate bulk buying through effective product quota management,” he added.

Well Pharmacy has last week committed to holding the price of core lines where possible and introducing new competitively priced lines to meet the rising demand.

“We care for the health and wellbeing of our patients and customers and won’t seek to profiteer from this situation,” it said in a statement on Friday (13 March)

The chain has limited purchases of hand sanitiser in all its pharmacies to two per customer. The group also has pharmaceutical grade face masks available in store to meet the consumer requests.

Well said its supply chain network is coping well, with plenty of stock of key supplies.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less